Sanibel Captiva Trust Company’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-3,389
Closed -$510K – 393
2025
Q1
$510K Sell
3,389
-2,167
-39% -$363K 0.02% 270
2024
Q4
$1.03M Sell
5,556
-19,244
-78% -$3.71M 0.03% 220
2024
Q3
$4.88M Sell
24,800
-4,611
-16% -$958K 0.16% 108
2024
Q2
$6.08M Sell
29,411
-1,079
-4% -$244K 0.21% 96
2024
Q1
$8.26M Buy
30,490
+11,974
+65% +$2.86M 0.28% 86
2023
Q4
$4.38M Buy
+18,516
New +$3.64M 0.16% 104

Other funds holding CRL

Sanibel Captiva Trust Company's CRL Position: Q2 2025 in Review

Sanibel Captiva Trust Company sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 3,389 shares — an estimated $510K sold.

Sanibel Captiva Trust Company first reported a position in CRL in Q4 2023 and held it in 6 quarters. The position peaked at $8.26M in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Sanibel Captiva Trust Company reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Sanibel Captiva Trust Company sold 3,389 Charles River Laboratories shares in Q2 2025, an estimated $510K.
  • Sanibel Captiva Trust Company first reported a position in Charles River Laboratories in Q4 2023 and held it in 6 quarters.
  • Sanibel Captiva Trust Company's Charles River Laboratories position peaked at $8.26M in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2025, filed 13 Aug 2025.